New therapeutics in endometriosis: A review of hormonal, non-hormonal, and non-coding RNA treatments

54Citations
Citations of this article
109Readers
Mendeley users who have this article in their library.

Abstract

Endometriosis is defined as endometrial-like tissue outside the uterine cavity. It is a chronic inflammatory estrogen-dependent disease causing pain and infertility in about 10% of women of reproductive age. Treatment nowadays consists of medical and surgical therapies. Medical treatments are based on painkillers and hormonal treatments. To date, none of the medical treatments have been able to cure the disease and symptoms recur as soon as the medication is stopped. The development of new biomedical targets, aiming at the cellular and molecular mechanisms responsible for endometriosis, is needed. This article summarizes the most recent medications under investigation in endometriosis treatment with an emphasis on non-coding RNAs that are emerging as key players in several human diseases, including cancer and endometriosis.

Cite

CITATION STYLE

APA

Brichant, G., Laraki, I., Henry, L., Munaut, C., & Nisolle, M. (2021). New therapeutics in endometriosis: A review of hormonal, non-hormonal, and non-coding RNA treatments. International Journal of Molecular Sciences, 22(19). https://doi.org/10.3390/ijms221910498

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free